Concepedia

Author

Wouter Koek

The University of Texas Health Science Center at San AntonioORCID

Also Known As

Koek, Wouter, W KOEK, W Koek, W. KOEK, W. Koek, W. M. Koek, WOUTER KOEK, Wouker Koek, Wouter Koek

272

Publications

7.1K

Citations

46

H-Index

121

Concepts

All Affiliations

The University of Texas Health Science Center at San AntonioPierre Fabre (France)Pierre Fabre (Germany)University of MichiganUniversity of Maryland, Baltimore
WK

About

Wouter Koek is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, neuropharmacology, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

36

100

3.8K

2

Social Sciences

29

58

2.1K

3

Health Sciences

20

24

998

4

Education

1

1

22

5

Natural Sciences

1

1

20

Wouter Koek

×

165

Publications

6.6K

Citations

44

H-Index

YearCitations

MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.

Wouter Koek, J H Woods, Gail Winger

Journal of Pharmacology and Experimental Therapeutics

1988

306

WIN55,212‐2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson’s disease

David A. Price, Alex Martinez, Alexandre Seillier,

European Journal of Neuroscience

2009

235

Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects.

Wouter Koek, F. C. Colpaert

Journal of Pharmacology and Experimental Therapeutics

1990

202

Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice

Nicole L. Baganz, Rebecca E. Horton, Alfredo S. Calderon,

Proceedings of the National Academy of Sciences

2008

164

A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects

Ellen Kraig, Leslie A. Linehan, Hanyu Liang,

Experimental Gerontology

2018

162

Opiate self-administration as a measure of chronic nociceptive pain in arthritic rats

F. C. Colpaert, J.P. Tarayre, M. Alliaga,

Pain

2001

138

Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia

Françis C. Colpaert, J.P. Tarayre, Wouter Koek,

Neuropharmacology

2002

136

Differential effects of direct and indirect dopamine agonists on eye blink rate in cynomolgus monkeys.

Mark S. Kleven, Wouter Koek

Journal of Pharmacology and Experimental Therapeutics

1996

134

Novel Derivatives of 2-Pyridinemethylamine as Selective, Potent, and Orally Active Agonists at 5-HT<sub>1A</sub> Receptors

Bernard Vacher, Bernard Bonnaud, Philippe Funes,

Journal of Medicinal Chemistry

1999

107

F15599, a highly selective post-synaptic 5-HT1A receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity

Marie‐Bernadette Assié, Laurent Bardin, Agnès L. Auclair,

The International Journal of Neuropsychopharmacology

2010

106

Page 1